Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Clinical Laboratory Services Market - Growth, Trends, and Forecasts (2020 - 2025)

Published by Mordor Intelligence Pvt Ltd Product code 922037
Published Content info 114 Pages
Delivery time: 2-3 business days
Back to Top
Clinical Laboratory Services Market - Growth, Trends, and Forecasts (2020 - 2025)
Published: June 1, 2020 Content info: 114 Pages

The clinical laboratory services market is primarily driven by the rising incidences of chronic diseases and the increasing demand for accurate disease diagnosis, along with the government's focus on public-private partnerships. However, the lack of medical laboratories, advanced diagnostic equipment, and inadequately trained laboratory staff are restraining the market's growth. Most of the developing countries across the globe are facing a high prevalence of communicable diseases along with the rising prevalence of non-communicable diseases. As per the World Health Organization 2018, 41 million, or 71% of the global deaths were due to noncommunicable diseases (NCDs). People across the developing countries are becoming more selective about the health services they get. Due to the favorable reimbursement and developed healthcare systems of countries such as the United States, France, the UK, etc., there is a high demand for laboratory services which is propelling the growth of the market studied.

The progression of chronic diseases can be prevented through lifestyle changes. However, the early diagnosis of an underline disease is necessary for interventions to be effective. Thus, owing to the increasing burden of chronic diseases, the volumes of diagnostic tests are expected to increase rapidly, resulting in the expansion of the market.

Key Market Trends

Independent Laboratories to Register Healthy Growth

The demand for laboratory testing is increasing, due to the increasing incidences of chronic diseases, thereby increasing the demand for the accurate diagnosis of different diseases. In highly populated countries like India and China where a significant chunk of the population does not have access to proper medical diagnostic facilities, there is a huge opportunity for independent laboratories. In countries like Nigeria, the laboratory services are being integrated with the three-tier public health system at the primary, secondary, and tertiary levels. Besides these, there are reference laboratories, research laboratories, and disease-specific reference laboratories to provide services for complex and special tests.

The independent laboratories are coming up with highly advanced types of equipment and are providing multiple test types which is enabling patients to access the service as per their convenience. Hence, independent laboratories are expected to witness healthy growth.

United States Holds the Largest Share of the Market

The major factor driving growth of the United States clinical laboratory services market is the presence of key players and the government organizations in the country which enables the awareness among the general population and allows them to access the services conveniently. For instance, the American Clinical Laboratory Association is a not-for-profit organization offers members the benefits of representation, education, information, and research. Also, the high adoption of technological advancements in the country backed up by proper quality measures is playing an important role in delivering quality, efficient and effective service to the growing healthcare industry.

Competitive Landscape

The market for clinical laboratory services is moderately competitive and various global, as well as local companies, are present in the market. A major share of the market is grabbed by the global players and local companies are also focusing on delivering innovative services to the people which is allowing these companies to establish their considerable place in this market. With a rising need for technology, it is expected that few new entrants will be seen in the market in the future and these players will gain a substantial share.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Table of Contents
Product Code: 67131

Table of Contents


  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Technological Advancements in the Clinical Testing
    • 4.2.2 Raised Burden of Target Diseases and Rising Demand for Early Detection
  • 4.3 Market Restraints
    • 4.3.1 Regulatory Issues
    • 4.3.2 Lack of Skilled Professionals
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 By Test Type
    • 5.1.1 Clinical Chemistry
    • 5.1.2 Immunology
    • 5.1.3 Cytology
    • 5.1.4 Genetic
    • 5.1.5 Microbiology
    • 5.1.6 Hematology
    • 5.1.7 Others
  • 5.2 By Service Provider
    • 5.2.1 Independent and Reference Laboratories
    • 5.2.2 Hospital-based Laboratories
  • 5.3 Geography
    • 5.3.1 North America
      • United States
      • Canada
      • Mexico
    • 5.3.2 Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • 5.3.3 Asia Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • GCC
      • South Africa
      • Rest of Middle East and Africa
    • 5.3.5 South America
      • Brazil
      • Argentina
      • Rest of South America


  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Fresenius Medical Care
    • 6.1.3 QIAGEN
    • 6.1.4 Quest Diagnostics Incorporated
    • 6.1.5 Siemens AG
    • 6.1.6 Novartis AG
    • 6.1.7 LabCorp
    • 6.1.8 NeoGenomics
    • 6.1.9 Charles River Laboratories
    • 6.1.10 OPKO Health


Back to Top